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RADIATION ONCOLOGY PHYSICS

Modeling AeroForm tissue expander for postmastectomy
radiation therapy
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Abstract
The AeroForm chest wall tissue expander (TE) is a silicon shell containing a metallic
CO2 reservoir, placed surgically after mastectomy. The patient uses a remote control
to release compressed CO2 from the reservoir to inﬂate the expander. AeroForm
poses challenges in a radiation therapy setting: The high density of the metallic reservoir causes imaging artifacts on the planning CT, which encumber structure deﬁnition
and cause misrepresentation of density information, in turn affecting dose calculation. Additionally, convolution‐based dose calculation algorithms may not be well‐suited to calculate dose in and around high‐density materials. In this study, a model of
the AeroForm TE was created in Eclipse treatment planning system (TPS). The TPS
model was validated by comparing measured to calculated transmission through the
AeroForm. Transmission was measured with various geometries using radiochromic
ﬁlm. Dose was calculated with both Varian’s Anisotropic Analytical Algorithm (AAA)
and Acuros External Beam (AXB) algorithms. AAA and AXB were compared using
dose proﬁle and gamma analyses. While both algorithms modeled direct transmission
well, AXB better modeled lateral scatter from the AeroForm TE. Clinical signiﬁcance
was evaluated using clinical data from four patients with AeroForm TEs. The AeroForm TPS model was applied, and RT plans were optimized using AAA, then re‐calculated with AXB. Structures of clinical signiﬁcance were deﬁned and dose volume
histogram analysis was performed. Compared to AXB, AAA overestimates dose in
the AeroForm device. Changes in clinically signiﬁcant regions were patient‐ and plan‐
speciﬁc. This study proposes a clinical procedure for modeling the AeroForm in a
commercial TPS, and discusses the limitations of dose calculation in and around the
device. An understanding of dose calculation accuracy in the vicinity of the AeroForm
is critical for assessing individual plan quality, appropriateness of different planning
techniques and dose calculation algorithms, and even the decision to use the AeroForm in a postmastectomy radiation therapy setting.
KEY WORDS

AAA, Acuros, AeroForm, dose calculation, high density, postmastectomy radiation therapy,
tissue expander
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1 | INTRODUCTION

ET AL.

the Collapsed Cone Convolution (CCC) algorithm (Philips Healthcare,
Fitchburg, WI, USA).16

For breast cancer patients with greater than four positive lymph

Manufacturers of the AeroForm TE recommend deﬁning the

nodes, positive or close margins, or a tumor greater than 5 cm, the

device in the TPS and applying appropriate density overrides.9 In a

National Comprehensive Cancer Network guidelines recommend

2014 study, Moni et al evaluated the dosimetric impact of AeroForm

postmastectomy radiation therapy (PMRT). Currently there is no

TE in Varian Eclipse TPS (Varian Medical Systems, Palo Alto, CA,

consensus on the optimal method and timing of postmastectomy

USA).17 Moni placed OSLDs at various locations around the Aero-

1–3

One common

Form TE on anthropomorphic phantom. The set‐up was imaged and

technique is the two‐stage breast reconstruction. In this method, a

an RT plan was created and delivered. The accuracy of AAA with

tissue expander (TE) is placed at the time of mastectomy. In the fol-

and without heterogeneity corrections was evaluated by comparing

lowing weeks, the TE is gradually expanded to the desired size, and

the calculated dose to the OSLD‐measured dose. Moni reported

PMRT is delivered after expansion is complete. At a later time, the

agreement between AAA and measured data within 5%, except at

TE is exchanged for a permanent implant.4–6

the reservoir‐chest wall‐interface, where the measured dose was

breast reconstruction for patients receiving PMRT.

Several types of TEs are available. The CPX® (Mentor, Irvine,

consistently 5–15% higher than calculated. Moni was also unable to

CA, USA), Natrelle® (ALLERGAN, Santa Barbara, CA, USA), Der-

observe the predicted “dose shadow” effect with OSLD measure-

maspanTM and AlloX2® (Sientra, INC., Santa Barbara, CA, USA)

ments, possibly due to uncertainty in detector placement.17 These

TEs consists of a silicon shell containing a magnetic injection port.

areas are of signiﬁcant clinical importance; clinicians require accurate

The TE is expanded by externally aligning a magnetic port locating

dose calculation in these regions to assess overall RT plan quality.

device to the internal magnetic port (IMP). Once aligned, saline is

In a 2014 study, Tran et al measured transmission through vari-

injected percutaneously through the IMP to inﬂate the TE.

ous components of the AeroForm CO2 reservoir using an ion cham-

Patients

ber.18 The authors reported physical density assignments in Pinnacle

receive

weekly

injections,

over

the

course

of

6–

7,8

8 weeks.

TPS that resulted in dose calculations in agreement with measured

The AeroForm TE (AirXpanders, Palo Alto, CA, USA) consists of a

transmission data. Signiﬁcant differences existed between the exper-

silicon shell containing a stainless steel reservoir of compressed CO2.

imentally determined density and vendor‐reported density. Using an

The TE is expanded using a hand‐held remote control, which sends a

anthropomorphic phantom with the AeroForm TE, Tran et al com-

radio‐frequency signal to the expander. The TE in turn releases small

pared dose calculated in Pinnacle TPS to dose measured with TLDs

volumes of compressed CO2 from the reservoir into the silicon shell.

at various locations. Percent differences between calculated and

The expansion is patient controlled; typically a patient releases 10 cc

measured doses ranged between −10 and +15%.18

CO2 at a time, up to three times per day, over the course of 4–

This study deals with the accuracy of modeling of the Aeroform

6 weeks. If radiation is indicated, the patient is typically simulated

TE in Eclipse TPS using both AAA and Acuros External Beam (AXB)

and treated after expansion is complete.8,9

algorithms (Varian Medical Systems, Palo Alto, CA, USA). AAA is

Tissue expanders pose particular challenges in a radiation oncol-

under the general class of superposition/convolution algorithms in

ogy setting. The high‐density metallic components of both types of

which total dose is computed by superposition/convolution of the

TE cause artifacts in treatment planning CT images. The degradation

primary dose with scatter dose kernels. Such algorithms account

of image quality makes target deﬁnition more challenging, and mis-

indirectly and approximately for electron transport in heterogeneous

representation of CT number in and around the TE may cause errors

media. AAA uses a 3D pencil‐beam kernel, which accounts for

in dose calculation. 16‐bit CT reconstruction corrected using metal

changes in electron density perpendicular to the beam direction by

artifact reduction (MAR) reconstruction techniques may minimize the

applying radiological depth scaling.19 The AXB algorithm is consid-

10,11

However, even with accu-

ered a grid‐based Boltzmann Solver (GBBS) as it analytically solves

rate CT information, convolution dose calculation algorithms are not

the Boltzmann transport equation using interaction cross sections

designed for use with high‐Z materials.12,13

speciﬁc to the relevant material and energy. The electron ﬂuence

effects of artifacts on image quality.

Previous literature has proposed various solutions dealing with

spectrum in each voxel is computed, and dose is subsequently deter-

TEs in a radiation treatment planning systems (TPS).14 Chen et al.

mined by integration over energy of the product of the electron ﬂu-

and Yoon et al. studied the dosimetric impact of TEs utilizing an

ence spectrum and the relevant cross section within the voxel,

IMP.15,16 Both authors corrected the CT image by applying density

divided by the mass density of the voxel.20 As such, the Acuros AXB

overrides to the IMP and surrounding artifacts. They deﬁned the

characterizes electron transport, albeit approximately, more like a

IMP using known physical dimensions of the magnetic disk, and a

Monte Carlo‐based algorithm. A GBBS algorithm such as AXB may

density override determined by transmission measurements. Chen

therefore better suited to calculate dose near the various heteroge-

et al. found good agreement between transmitted depth‐dose pro-

neous boundaries of the AeroForm TE.

ﬁles measured with ﬁlm and dose calculated using the Anisotropic

Convolution algorithms such as Pinnacle CCC and Eclipse AAA

Analytical Algorithm (AAA) (Varian Medical Systems, Palo Alto, CA,

underestimate dose perturbation occurring in the presence of high‐

USA).15 Yoon et al. described good agreement between transmitted

density materials. The most signiﬁcant inaccuracies occur near the

depth‐dose proﬁles measured with TLDs and dose calculated using

boundaries of the high‐density object, where effects of electron
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backscatter and lateral scatter are not accounted for. AAA also

a 20 cm FOV with a 1 mm slice thickness using 120 kVp and

underestimates attenuation from high‐density materials.12,13

500 mAs. A 16‐bit reconstruction was generated.

For patients with TE that uses an IMP, the known inaccuracies
21,22

of convolution algorithms may have a limited clinical impact.

The

TPS models of both CO2 reservoir sizes were created in Eclipse
(platform 13.5). The CT scans were imported into the TPS and indi-

high‐density magnet is generally more than 1 cm away from patient

vidual components were identiﬁed and contoured using automatic

tissue, so inaccuracies in lateral scatter dose are conﬁned to the sal-

thresholding techniques. The dimensions of the component struc-

ine ﬁlling the TE and the IMP itself. AAA’s underestimation of atten-

tures were veriﬁed against manufacturer‐provided speciﬁcations. Fig-

uation through the IMP might affect the accuracy of the dose

ure. 2 details the individual components on a coronal CT slice. Using

calculated in the “dose shadow” region. However, as discussed previ-

Eclipse, the TPS models were saved as phantom image and structure

ously, this effect can be mitigated by assigning an experimentally

sets. The appropriate model could then be rigidly registered with any

determined relative electron density (RED) value for the IMP in the

clinical patient planning CT series or experimental setup containing a

clinician’s TPS.

TE, as shown in Fig. 3. This is particularly useful in clinical cases

The AeroForm TE employs a geometry where known inaccura-

where artifacts are exacerbated by patient anatomy, expander orien-

cies of a convolution algorithm may have a greater clinical signiﬁ-

tation, or multiple expanders, where the expanders are difﬁcult to

cance. The high‐density CO2 reservoir is only separated from the

deﬁne. Patient planning CTs were acquired using a typical breast

patient chest wall by the thin silicon shell of the TE. A convolu-

protocol: 60 cm FOV with a 3 mm slice thickness using 120 kVp and

tion algorithm’s underestimation of lateral scatter in this region

50 mAs. A 16‐bit reconstruction was generated both with and with-

might lead to a hot spot in the chest wall adjacent to the reser-

out MAR reconstruction.

voir that is not evident in the calculated dose distribution. As with
the IMP TEs, a convolution algorithm might also underestimate
the effect of the dose shadow. Measurements discussed previ-

2.B | Validation of the AeroForm TPS model

ously by Moni et al and Tran et al are not inconsistent with these

Several simple geometries were used to validate the TE models. Each

predictions. However, it is possible that a GBBS algorithm such as

expander was oriented vertically and horizontally on slabs of solid

AXB, might provide more accurate dose calculations in these clini-

water, as shown in Fig. 4. A CT scan of each geometry was acquired

cally signiﬁcant areas. Studies have shown that AXB achieves

and imported into Eclipse TPS. Individual components of each

accuracy similar to Monte Carlo, even in and around high‐density

expander were deﬁned by rigidly registering the acquired CT scan to

heterogeneities.13

the appropriate TPS model, as described previously. The solid water

This study aims ﬁrst to describe a method for modelling the

and air surrounding the expanders were also contoured, so appropri-

AeroForm in Eclipse TPS. It is the authors’ hope that the procedure

ate densities could be assigned to correct for streaking artifacts. A

can be easily implemented into any clinician’s radiation therapy TPS.

single open ﬁeld plan was created to deliver an AP, 20 cm2 × 20

The TPS model will be optimized and evaluated for both AAA and

cm2, 6 MV beam to each geometry. Dose was calculated using a

AXB, employing techniques described Chen et al and Yoon et al.

1 mm grid size for each expander size and geometry, with both AAA

Finally, the dosimetric impact of the AeroForm TE will be evaluated

and AXB dose calculation algorithms (version 13.5.35).

using clinical patient data. Differences in plan outcome based on
dose calculation algorithm will be discussed. An understanding of
dose calculation accuracy in the vicinity of the AeroForm TE is critical for assessing individual plan quality, appropriateness of different
planning techniques and dose calculation algorithms, and even the
decision to use the AeroForm TE in a PMRT setting.

2 | MATERIALS AND METHODS
2.A | Imaging and modeling the AeroForm TE
The AeroForm TE is available in three sizes: 400, 600, and 800 cc.
The 400 and 600 cc sizes utilize a CO2 reservoir 7.6 cm in length

(a)

(b)

(c)

and 1.9 cm in diameter. The 800 cc TE uses a reservoir 9.0 cm in
length and 1.9 cm in diameter. Both sizes of AeroForm reservoir are
shown in Fig. 1, with the Natrelle® IMP for comparison.
Each reservoir size was imaged using a Philips Brilliance Big Bore

CO2
Reservoirs

Internal
Magnec Port

CT scanner (Philips Health Care, Cleveland, OH, USA). The AeroForm
reservoir was aligned such that the long axis was perpendicular to
axial plane, so as to minimize artifacts. Helical CTs were acquired for

F I G . 1 . (a) CO2 reservoir for 800 cc AeroForm (b) CO2 reservoir
for 400 and 600 cc AeroForm (c) Magnasite magnetic injection port.

90

|

DZIEMIANOWICZ

Stainless steel bottle

(a)
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(b)

F I G . 4 . (a) Horizontal and (b) vertical orientations of the AeroForm
TE for dose measurement. Gafchromic ﬁlm is sandwiched between a
1 cm slab of solid water and 5 cm of solid water backscatter.
The planned AP 20 cm2 × 20 cm2 6 MV beam was delivered to

Stainless steel &
copper windings

each set‐up using a Varian TrueBeam® linear accelerator (Varian
Medical Systems, Palo Alto, CA, USA). For each geometry, a Gafchromic EBT3 ﬁlm (Ashland Specialty Ingredients GP, Bridgewater,
NJ, USA) was placed between solid water slabs at a depth of 1 cm
(as shown in Fig. 4). The ﬁlm was scanned using a Vidar Dosimetry
Pro Advantage ﬁlm digitizer (Vidar Systems Corporation, Herndon,
VA, USA) according to departmental protocol.23 A calibration curve
speciﬁc to the ﬁlm batch and energy was created using the same
protocol. The dose plane measured with ﬁlm was compared to the
dose plane calculated in Eclipse using Matlab (Mathworks, Natick,

Rubber cap

MA, USA) based in‐house software. Gamma index maps, and line
proﬁles were generated to evaluate the accuracy of the two dose
calculation methods for each set‐up. Gamma analysis was performed

F I G . 2 . Coronal CT slice of the 400–600 cc AeroForm CO2
reservoir using optimal geometry and acquisition technique.
Individual components are deﬁned and veriﬁed with manufacturer
speciﬁcations.

to quantify dose calculation accuracy. Gamma parameters of 3%
dose difference and 3 mm distance to agreement were used for all
analyses.
In the planning CT, density overrides were applied to the air and
solid water to correct for artifacts. Initially, CT values of the various
components of the CO2 reservoir were assigned based on manufacturer speciﬁcations. In AAA, initial CT values were assigned to
achieve a physical density as near as possible to the vendor‐stated
physical density. In AXB, initial CT values were assigned based on
the Eclipse default material values for stainless steel. Upon analysis,
the densities of the various AeroForm components were adjusted to
best ﬁt measured data. Re‐assignment of CT value, dose calculation,
and comparison to measured data was then repeated iteratively to
identify the optimal density assignments that resulted in the best
agreement between measured and calculated data for both AAA and
AXB.

2.C | Evaluation of the AeroForm TPS model in
clinical cases
F I G . 3 . Bilateral AeroForm implants cause signiﬁcant artifacts in
the patient CT. Reservoir components are deﬁned by registering the
patient CT with to the treatment planning system model (shown in
the “moving window”).

Patient data were analyzed as part of an IRB‐approved retrospective
study. Four postmastectomy patients with AeroForm TEs were simulated. Patients 1, 2, and 4 had bilateral 600 cc AeroForm implants.

DZIEMIANOWICZ
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Patient 3 had a single 800 cc AeroForm implant. All three patients

optimized using electronic tissue compensation (ECOMP) technique.

were simulated on a Philips Brilliance Big Bore CT scanner, using

To achieve acceptable coverage, the dose shadow and chest wall

helical CT scans, with 3‐mm slice thickness, 60 cm FOV, 120 kVp

regions were “boosted.” An example of the resulting ﬂuence is

and 400 mAs and with a 16‐bit reconstruction. All CT scans were

shown in Fig. 6.

reconstructed both with and without MAR for evaluation. The non‐

Initial planning employed AAA dose calculation algorithm. After a

MAR scan was used as the primary planning CT, due to reconstruc-

satisfactory plan was achieved and reviewed by a physician, each

tion artifacts (see section 3.A).

plan was re‐calculated using AXB dose calculation algorithm. Beam

The components of the AeroForm device were deﬁned by regis-

parameters were unchanged. Patients 1, 3, and 4 were planned to a

tering the appropriate TPS model to the planning CT. The expander

total dose of 50 Gy, and patient 2 was planned to a total dose of

balloon was also contoured: this structure includes the air cavity

50.4 Gy.

inside the AeroForm’s silicon shell, and excludes the metal CO2

Dose distributions calculated by AAA and AXB were compared

reservoir. Normal critical structures were contoured and reviewed by

by evaluating dose volume histograms (DVHs) of the structures of

the physician according to departmental protocol. The target breast

interest deﬁned above. For each of the patient, the mean (Dmean)

was contoured by the physician. A structure called “PTV_EVAL” was

and maximum (Dmax) dose of each structure was tabulated for both

created for plan evaluation. PTV_EVAL consists of the target breast

the AAA‐ and AXB‐calculated plan. The differences between values

as deﬁned by the physician, minus the entire AeroForm expander

calculated by the two algorithms are reported.

(the CO2 reservoir and the expander balloon). PTV_EVAL represents
the clinically signiﬁcant patient tissue inside the target breast that
requires adequate dose coverage.
Two additional structures were deﬁned for the purpose of evaluating areas of particular interest near the CO2 reservoir. “Chest wall
AF”

is deﬁned as the tissue between the lung and expander balloon,

and within 2 cm of the CO2 reservoir. “Dose shadow

3 | RESULTS & DISCUSSION
3.A | Imaging and modeling the AeroForm TE
Using optimal geometry and imaging technique, the AeroForm CO2

AF” is a cylin-

reservoir alone can be exquisitely imaged without a MAR reconstruc-

drical projection of the CO2 reservoir along its long axis in PTV_E-

tion. The CT technique described previously was used to create the

VAL. Both structures are shown in Fig. 5.

TPS models of the AeroForm device in Eclipse TPS (Fig. 2). Mea-

The optimized CT values (Table 2) were assigned to all CO2

sured dimensions of the stainless steel CO2 bottle and the stainless

reservoir components. Additionally, density overrides were applied

steel and copper windings (SSCW) agreed within 1 mm of vendor

to the expander balloon and PTV_EVAL structures to correct for

provided speciﬁcations. Additionally, the TPS model included the

streaking artifacts. Density overrides were only necessary in the CT

rubber cap, for which the vendor did not provide speciﬁcations.
Unfortunately, such a CT technique is not practical for a patient

slices where the CO2 reservoir was visible.
An experienced dosimetry team planned all four cases using

breast simulation. First, the AeroForm TE is surgically placed with

6 MV tangential geometries. All plans included the use of 0.5 cm of

the long axis parallel to the axial plane. It is not possible to orient

bolus over the entire breast every other day. Planning goals for

the patient on the CT to achieve the optimal imaging of the reser-

AeroForm structures are shown in Table 1. Dose distributions were

voir. Furthermore, many patients have bilateral TEs, increasing the
streaking artifact effect on the axial slices where both reservoirs are
visible. Finally, a small FOV, 1‐mm slice thickness CT protocol is not
suitable for a breast CT acquisition.
Both reconstructions were made available during contouring, but
the non‐MAR reconstruction was used as the primary planning CT.

d

Planners observed that the MAR reconstruction offered better visu-

e f
g
b

alization of the CO2 reservoir and the external contour. However,

c

near tissue‐air cavity interfaces such as the chest wall‐lung or
PTV_EVAL‐expander balloon boundaries, the MAR reconstruction

a

a. PTV_EVAL
b. Chest wall AF
c. Dose shadow AF
d. Expander balloon
e. Stainless steel bole
f. Stainless steel & copper windings
g. Rubber cap
F I G . 5 . Axial CT of a patient breast with AeroForm TE, with
structures created for density overrides and plan evaluation.

sometimes generated high‐density “cavity ﬁlling” artifacts, as shown
in Fig. 7. Therefore, the non‐MAR reconstruction was more useful in

T A B L E 1 Planning goals for AeroForm structures.
Structure

Goal

Acceptable

PTV_EVAL

Dmin > 5%

Dmin > 90%

PTV_EVAL

Dmax < 108%

D1cc < 110%

Reservoir

Dmax < 65Gy

Dmax < 75Gy
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of the AeroForm for the horizontal geometry [Fig. 4(a)]. Calculated
dose proﬁles are shown before and after the RED assignments were
optimized, for both AAA and AXB. In AAA, the initial model (which
assigned densities based on manufacturer speciﬁed physical densities) overestimated dose transmitted through both the stainless steel
bottle (SSB) and the SSCW. After the RED of the SSCW was
adjusted to 6.1 (Table 2), the measured and calculated transmission
through the SSCW agreed within 3%. The RED of the SSB was
assigned the maximum allowable value (6.58). However, even at the

LAT

maximum value, AAA overestimated the transmission through the

MED

solid parts of the SSB. AAA did not accurately model the dose at
F I G . 6 . Fluence maps of tangent ﬁelds (Patient 2). To achieve
adequate dose coverage, ﬂuence is boosted in the chest wall and
AeroForm dose shadow regions.

and near boundaries of individual components. Where the ﬁlm
showed steep gradients between components, AAA calculated more
rounded shoulders.
In AXB, the initial model (which assigned RED based on the

(a)

non-MAR

(b)

Eclipse material density default value for stainless steel) underesti-

MAR

mated transmission through the SSCW, and slightly underestimated
transmission through the SSB. The density assignments were
adjusted such that calculated and measured transmission through

“cavity
ﬁlling”
arfacts

both materials agreed within 3%. The original TPS model did not
include the rubber cap, as there were no vendor speciﬁcations for
this component. However, exclusion of the cap caused a discrepancy
between the calculated and measured dose in the affected region.
Therefore, the cap was added to the TPS model. The cap dimensions
were deﬁned using the CT acquisition described in section 2.A, and
the assigned RED was optimized in the same manner as the other
components. The rubber cap was not included in the AAA model,
because it exacerbated the dose shoulder effect evident at compo-

F I G . 7 . CT of a patient with bilateral AeroForm implants, split
window between (a) non‐MAR and (b) MAR CT reconstructions.
MAR causes “cavity ﬁlling” artifacts in the expander balloon and
lungs.

nent boundaries in the AAA calculated dose.

deﬁning the lungs and the expander balloon. Due to the severe

99% for both AAA and AXB. However, in the region directly adja-

streaking artifacts (particularly where patients had bilateral expan-

cent to the reservoir (between 0 and 1 cm from the device edge),

ders), lung and external structures created using the auto‐contouring

AAA consistently underestimated dose and nearly all points within

tools required manual editing on slices where the reservoir was

1 cm failed the gamma criteria. For AXB, Gamma pass rates in this

visible.

region were greater than 98%.

3.B | Validation of the AeroForm TPS model

calculated dose planes. The dashed lines in Fig. 9(a) indicate the

Figure 9 shows Gamma analysis results from the ﬁlm measurement. Using optimized RED values, Gamma pass rates in the region
where the reservoir directly attenuated the beam were greater than

Figure 10 shows various proﬁles of the ﬁlm and AAA‐ and AXB‐
location of each proﬁle. Using the optimized RED overrides, both
Transmission through the AeroForm CO2 reservoir was best mod-

calculation models adequately predict transmission directly through

elled using the RED assignments shown in Table 2. Figure 8 com-

the reservoir. However, AAA underestimates dose in the region

pares the measured and calculated dose proﬁles along the long axis

immediately adjacent to the reservoir. Additionally, the maximum
RED value allowed by the AAA dose calculation algorithm is 6.5845.

T A B L E 2 Manufacturer speciﬁed physical densities and
experimentally optimized RED values for various components of
AeroForm TE.
Reservoir structure

ρ (g/cc)

RED AAA

RED AXB

Stainless steel CO2 bottle

8.1

6.6 (max)

6.1

Stainless steel & copper windings

5.5

6.1

5.1

Rubber cap

–

–

1.1

AAA, anisotropic analytical algorithm; AXB, acuros external beam; RED,
relative electron density.

Even using the maximum RED value, transmission through the solid
part of the SSB is slightly overestimated by AAA.

3.C | Evaluation of the AeroForm TPS model in
clinical cases
An example planned dose distribution for Patient 3 is shown in
Fig. 11, as calculated by (a) AAA and (b) AXB, (both using the optimized AeroForm TPS model). The plan was originally calculated using

DZIEMIANOWICZ
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Dose Proﬁles: Measured v. Inial & Final TPS Models

1.2
1

Film
AXB - inial TPS Model
AXB - Final TPS Model
AAA - Inial TPS Model
AAA - Final TPS Model

Dose [Gy]

0.8

F I G . 8 . Measured and calculated dose
proﬁles before and after relative electron
density assignment optimization in the
treatment planning system model.
Schematic insert indicates geometry,
reservoir overlay illustrates AeroForm
component locations.

0.6
0.4

Rubber Stainless Steel
Stainless Steel Bole
Cap & Copper Windings

0.2
0

0

10

20

30

40

50
60
70
Posion [mm]

80

90

100

110

AAA, and optimized using ECOMP technique. When the plan was

between the AAA and AXB calculated doses are also reported in

recalculated using AXB, the dose in the CO2 reservoir and expander

Tables 3 and 4.

balloon decreased. However, this change may not be clinically rele-

The DVH plots show that, compared to AXB, AAA consistently

vant, as these structures do not include patient tissue. The locations

overestimates dose in the CO2 reservoir and in the expander bal-

and magnitudes of hot spots in the PTV_EVAL do not appear to be

loon. Dmean of the CO2 reservoir is between 5% and 8% higher

greatly altered. A change in dose distribution is evident at the chest

when calculated by AAA. Dmean of the expander balloon is 6 to 13%

wall region adjacent to the reservoir. Similar differences and similari-

higher when calculated by AAA. The difference in Dmax is highly vari-

ties between AAA and AXB were observed for all four patients. Fig-

able.

ure 12 shows DVH plots of various structures of interest for all

The changes in dose distribution in patient tissue are more com-

patients. The mean and maximum doses of each structure are tabu-

plex. In evaluating the entire PTV_EVAL volume, differences

lated in Tables 3 and 4, respectively. The percent difference

between AAA and AXB appear to be minimal; changes in mean dose

(a)

(b)

(c)

(d)

(e)

F I G . 9 . (a) Dose measured with ﬁlm (b) Dose calculated with anisotropic analytical algorithm (AAA) (c) Film v. AAA Gamma analysis (d) Dose
calculated with Acuros External Beam (AXB) (e) Film v. AXB Gamma analysis. Schematic insert indicates geometry. Dashed lines indicate the
dose proﬁles shown in Fig 10.
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F I G . 1 0 . Measured (ﬁlm) and calculated dose proﬁles comparing the AAA and AXB TPS model in various orientations, as shown by the
schematic inserts. The dashed lines in Fig. 8 indicate the locations of each proﬁle: (i) length of horizontal reservoir, width of horizontal
reservoir through the (ii) stainless steel bottle (iii)solid stainless steel (iv) copper windings, and (v) width of vertical reservoir in Fig. 8.
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(a)

AAA

(b)

AXB

F I G . 1 1 . Dose distribution for Patient 3
calculated with (a) AAA and (b) AXB.
Compared to AXB, AAAoverestimates dose
in the expander balloon and reservoir. The
dose distribution in PTV_EVAL is
mostaffected in the chest wall region
adjacent to the reservoir.

F I G . 1 2 . DVHs for structures of interest (a) CO2 reservoir (b) expander balloon (c) PTV_EVAL (d) doseshadow AF (e) chest wall AF Four
patient plans were calculated using AAA and AXB..
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T A B L E 3 Mean dose for various regions of interest, calculated with AAA and AXB.
Patient No. 1
Mean dose

AAA (Gy)

AXB (Gy)

CO2 Reservoir

45.2

42.9

Patient No. 2
Δ (%)
5.4%

AAA (Gy)

AXB (Gy)

49.2

46.8

Patient No. 3
Δ (%)
5.0%

AAA (Gy)

AXB (Gy)

51.2

48.0

Patient No. 4
Δ (%)
6.9%

AAA (Gy)

AXB (Gy)

48.3

44.8

Δ (%)
7.7%

Expander balloon

54.3

49.2

10.4%

53.2

47.3

12.5%

53.2

47.3

12.6%

53.8

50.7

6.2%

PTV_EVAL

51.1

51.4

−0.6%

50.6

51.3

−1.3%

49.1

49.2

−0.3%

52.1

52.8

−1.3%

Chest wall AF

49.6

52.2

−5.0%

48.7

49.2

−1.1%

49.9

50.4

−1.1%

52.1

54.4

−4.2%

Dose shadow AF

49.8

50.1

−0.5%

48.3

49.3

−2.0%

53.0

54.2

−2.2%

47.2

49.6

−4.8%

AAA, Anisotropic Analytical Algorithm; AXB, Acuros External Beam.

T A B L E 4 Maximum dose for various regions of interest, calculated with AAA and AXB.
Patient No. 1

Maximum dose

AAA
(Gy)

AXB
(Gy)

CO2 Reservoir

60.7

55.7

Expander
balloon

67.7

58.7

Patient No. 2

Patient No. 3

Patient No. 4

AAA
(Gy)

AXB
(Gy)

Δ (%)

AAA
(Gy)

AXB
(Gy)

Δ (%)

AAA
(Gy)

AXB
(Gy)

8.9%

63.9

67.1

−4.7%

60.4

60.4

−0.1%

57.8

55.4

4.2%

15.4%

65.9

64.3

2.6%

65.6

61.6

6.4%

65.8

65.7

0.2%

Δ (%)

Δ (%)

PTV_EVAL

62.1

59.4

4.5%

62.3

63.5

−1.9%

62.3

61.9

0.6%

62.7

65.4

−4.1%

Chest wall AF

53.5

58.0

−7.8%

62.3

63.5

−1.9%

60.1

61.4

−2.1%

58.8

65.3

−10.0%

Dose shadow AF

59.6

58.4

2.0%

61.3

62.9

−2.5%

60.3

60.7

−0.6%

61.9

61.6

0.5%

AAA, Anisotropic Analytical Algorithm; AXB, Acuros External Beam.

to PTV_EVAL are less than 1.5% for all patients. Differences in

shape of the target DVH in the shoulder and tail region) will inform

speciﬁc subregions of PTV_EVAL appear to be somewhat patient‐

the planned beam modulation. As discussed previously, Dmax differ-

speciﬁc. AAA underestimated Dmean to the chest wall near the CO2

ences between AAA and AXB are variable, and therefore advanced

reservoir (chest wall

by 1.0% to 5.0%. The shape of the DVH

plan optimization using AAA versus AXB could result in a signiﬁcantly

shoulder and tail was sharper in AAA than in AXB for patients 2, 3,

AF)

different plans. If, for example, AAA underestimates dose to the chest

and 4, whereas the DVH for patient 1 appeared to be uniformly

wall, an optimized plan in AAA would increase ﬂuence to this region in

shifted. Dmean in the dose shadow region was between 0% and 5%

order to achieve good coverage. But calculated using AXB, the same

lower when calculated using AAA compared to AXB. Changes in

plan might have an unacceptable hot spot in the chest wall. If

DVH shape did not follow a distinct pattern. This may indicate that

advanced planning techniques will be used, it is essential that accurate

dose distribution differences in the dose shadow and chest wall

CT data and dose calculation methods are available.

regions are anatomy‐ and plan‐speciﬁc and cannot be easily generalized. Changes in Dmax were highly variable. This is partially explained
by the fact that plan optimization using AAA aimed speciﬁcally to

4 | CONCLUSION

control hot spots, whereas the re‐calculation with AXB did not
include any re‐optimization.

The AeroForm TE poses signiﬁcant challenges in a radiation therapy

Differences in Dmax and in the shoulder and tail regions of clinically

setting. A clinician must decide whether to treat patients with the

signiﬁcant structure DVHs may have a signiﬁcant impact on plan out-

implant, what planning technique to use, and how to evaluate plan

come. If the clinician decides to use a simple planning technique such

quality. To make these decisions, it is essential they have accurate

as wedged tangents, the AeroForm TE will decrease plan quality in a

CT and dose data, and understand the limitations of their TPS.

relatively predictable way: compared to an intact breast, dose will

This study describes a technique to model the AeroForm TE in a

decrease in the dose shadow region and in the chest wall. The clinician

commercially available TPS. The physical dimensions of the TPS model

must decide whether the suboptimal dose distribution will still accom-

agreed with vendor speciﬁed values. The TPS model therefore gives

plish clinical goals. Improved planned target coverage and hot‐spot

an accurate picture of the TE structure within the patient anatomy.

control might be achieved with advanced plan optimization tech-

Near AeroForm TEs, patient CT images suffer from signiﬁcant streak-

niques, such as ECOMP, ﬁeld‐in‐ﬁeld, or another form of inverse opti-

ing artifacts, and a MAR reconstruction may not be an adequate solu-

mization. These techniques modulate ﬂuence to limit dose to hot

tion. By facilitating accurate delineation of relevant anatomy, the TPS

spots, and increase dose to cold spots. However, with these tech-

model overcomes some challenges of contouring and plan evaluation

niques, the precise location and value of hot and cold spots (thus the

on a CT image with poor image quality due to artifact.

DZIEMIANOWICZ
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The RED assignments for the TE components were optimized
experimentally to maximize dose calculation accuracy. This resulted
in good agreement between measured and calculated dose for AXB

6.

dose calculation algorithm. Agreement between measured and calculated dose for AAA was acceptable in regions of direct transmission, but AAA underestimated dose in the regions adjacent to the

7.

reservoir. This result demonstrates the limits of a convolution‐based
dose calculation algorithm. For clinics with multiple algorithms avail-

8.

able, selecting an algorithm that accounts for effects of electron
transport (such as the AXB algorithm used in this study) will maximize dose accuracy in the vicinity of the TE. For both algorithms,

9.

an optimized TPS model of the TE will improve dose calculation
accuracy.

10.

The increased accuracy of the optimized TPS model, used in conjunction with AXB algorithm, has a clinical beneﬁt when applied to
patient data. The AeroForm TE presents unique challenges in achiev-

11.

ing adequate dose coverage of the target, particularly in the dose
shadow and chest wall regions. Advanced treatment planning tech-

12.

niques can be employed to achieve coverage in these areas. However,

techniques

such

as

ECOMP,

ﬁeld‐in‐ﬁeld,

or

inverse

optimization, rely on accurate dose calculations. This study compared

13.

dose calculated by AAA and AXB for ECOMP plans in clinical patient
data using the AeroForm TPS model. Dose differences between the
two algorithms existed in clinically relevant regions of patient anat-

14.

omy, such as the dose shadow, and the chest wall. Calculated dose
in these areas informs the optimization of the treatment plan, and

15.

thus directly affects the design of treatment beams. Beam optimization, and therefore target coverage, will be improved using the opti-

16.

mized TPS model of AeroForm in conjunction with a deterministic
dose calculation algorithm such as AXB.
17.
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